Outcome and Prognostic Index for Reduced-Intensity Allogeneic Stem Cell Transplantation (RIST) for Elderly Patients with De Novo Acute Myeloid Leukemia (AML): A Study From the AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JS']JSHCT)

被引：0

作者：

Kanamori, Heiwa ^{[1
]}

Fukuda, Takahiro ^{[2
]}

Taniguchi, Shuichi ^{[3
]}

Sawa, Masashi ^{[4
]}

Kondo, Tadakazu ^{[5
]}

Miyamura, Koichi ^{[6
]}

Kobayashi, Naoki ^{[7
]}

Kobayashi, Hikaru ^{[8
]}

Morishima, Yasuo ^{[9
]}

Hirokawa, Makoto ^{[10
]}

Atsuta, Yoshiko ^{[11
]}

Takami, Akiyoshi ^{[12
]}

机构：

[1] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2410815, Japan

[2] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan

[3] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan

[4] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Japan

[5] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto, Japan

[6] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan

[7] Sapporo Hokuyu Hosp, Dept Hematol, Sapporo, Hokkaido, Japan

[8] Nagano Red Cross Hosp, Dept Hematol, Nagano, Japan

[9] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan

[10] Akita Univ, Grad Sch Med, Akita 010, Japan

[11] Nagoya Univ, Sch Med, Nagoya, Aichi 466, Japan

[12] Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.1918.1918

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1918

引用

页数：2

共 50 条

[1] Prognostic Factors of Reducing Relapse in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation From Related Donor for Acute Myeloid Leukemia: The Japan Society for Hematopoietic Cell Transplantation (JS']JSHCT) AML Working Group
Yano, Shingo
Yokoyama, Hiroki
Nishimura, Rimei
Fukuda, Takahiro
Ogawa, Hiroyasu
Ohashi, Kazuteru
Kanamori, Heiwa
Tanaka, Junji
Sakamaki, Hisashi
Atsuta, Yoshiko
Takami, Akiyoshi
[J]. BLOOD, 2011, 118 (21) : 1332 - 1332
[2] Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia Transformed from Ph-Negative Myeloproliferative Neoplasm: A Study from the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JS']JSHCT)
Takagi, Shinsuke
Masuoka, Kazuhiro
Uchida, Naoyuki
Kurokawa, Mineo
Nakamae, Hirohisa
Tsudo, Mitsuru
Iwato, Koji
Ichinohe, Tatsuo
Atsuta, Yoshiko
Takami, Akiyoshi
[J]. BLOOD, 2014, 124 (21)
[3] Influence Of Donor Source On Relapse and Survival In Patients With Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis From The Japan Society For Hematopoietic Cell Transplantation (JS']JSHCT) AML Working Group
Yano, Shingo
Yokoyama, Hiroki
Uchida, Naoyuki
Kakihana, Kazuhiko
Fukuda, Takahiro
Kanamori, Heiwa
Ogawa, Hiroyasu
Nagamura, Tokiko
Tanaka, Junji
Morishima, Yasuo
Atsuta, Yoshiko
Takami, Akiyoshi
[J]. BLOOD, 2013, 122 (21)
[4] Reduced-Intensity Versus Myeloablative Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 45 Years with Acute Lymphoblastic Leukemia (ALL) in Remission: A Study From the ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JS']JSHCT).
Tanaka, Junji
Heiwa, Kanamori
Satoshi, Nishiwaki
Kazuteru, Ohashi
Shuichi, Taniguchi
Tetsuya, Eto
Hirohisa, Nakamae
Katayama, Yoshio
Morishima, Yasuo
Suzuki, Ritsuro
Kato, Koji
Sakamaki, Hisashi
Naoki, Nishimoto
Masauzi, Nobuo
[J]. BLOOD, 2012, 120 (21)
[5] Cytomegalovirus Reactivation After Allogeneic Stem Cell Transplantation Is Associated With a Reduced Risk Of Relapse In Patients With Acute Myeloid Leukemia: The Japan Society For Hematopoietic Cell Transplantation (JS']JSHCT) Transplantation-Related Complication Working Group
Takenaka, Katsuto
Nishida, Tetsuya
Asano-Mori, Yuki
Oshima, Kumi
Oshikawa, Gaku
Miyamura, Koichi
Eto, Tetsuya
Nakamae, Hirohisa
Sakamaki, Hisashi
Morishima, Yasuo
Suzuki, Ritsuro
Yamaguchi, Takuhiro
Fukuda, Takahiro
[J]. BLOOD, 2013, 122 (21)
[6] Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients
Jackson, Kathryn
Kennedy, Glen
Mollee, Peter
Marlton, Paula
Morris, Kirk
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 246 - 254
[7] Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JS']JSHCT)
Konuma, Takaaki
Mizuno, Shohei
Kondo, Tadakazu
Yamaguchi, Hiroki
Fukuda, Takahiro
Uchida, Naoyuki
Najima, Yuho
Kanamori, Heiwa
Ota, Shuichi
Nakamae, Hirohisa
Nakamae, Mika
Mizuno, Ishikazu
Sugita, Junichi
Onishi, Yasushi
Yokota, Akira
Takahashi, Satoshi
Kanda, Yoshinobu
Ichinohe, Tatsuo
Atsuta, Yoshiko
Yano, Shingo
[J]. ANNALS OF HEMATOLOGY, 2018, 97 (11) : 2173 - 2183
[8] Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
Lekakis, Lazaros
de Lima, Marcos
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 785 - 798
[9] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML)
Popat, U
Heslop, HE
Durett, A
May, R
Krance, RA
Brenner, MK
Carrum, G
[J]. BONE MARROW TRANSPLANTATION, 2006, 37 (06) : 547 - 552
[10] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML)
U Popat
H E Heslop
A Durett
R May
R A Krance
M K Brenner
G Carrum
[J]. Bone Marrow Transplantation, 2006, 37 : 547 - 552

← 1 2 3 4 5 →